IFNG and cancer: Intraepithelial cytotoxic T-cells (usually defined as CD8+) recognize cancer-specific antigens carried by presenting cells and generate local inflammation via cytokine release, particularly interferon-gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and recruitment of secondary immune actors that lead to the elimination of tumor cells (Figure 1).